IN THE NEWS

Featured Story

Learn More

Edward Ward participated in a clinical trial evaluating the AccuCinch system at age 74. Watch the video above to learn more about his experience with AccuCinch.

May 30, 2019
BusinessWire
Ancora Heart Enrolls First Patient in U.S. Early Feasibility Study of First-of-Its-Kind Investigational Heart Failure Therapy Learn more
September 24, 2018
BusinessWire
Ancora Heart Announces Positive Interim Analysis from Study of First-of-Its-Kind Heart Failure Therapy Learn more
May 30, 2018
BusinessWire
Ancora Heart Announces $17.8 Million Financing for First-of-Its-Kind Therapy for Systolic Heart Failure Learn more
May 14, 2018
BusinessWire
Ancora Heart Expands Enrollment of U.S. Early Feasibility Study for the AccuCinch System for Left Ventricular Repair Learn more
March 16, 2018
Minneapolis Heart Institute Foundation
MHIF Treats First Patient in AccuCinch Study for Mitral Regurgitation and Heart Failure Learn more
1 / 2

To Learn More

GET IN TOUCH